For the first half of the year, sales of listed pharmaceutical companies are recorded average level while operating profits are recorded lower than averages

For the first half of the year, listed companies are recorded at the average level of revenue growth, but operating profit was poor.

However, net profit is shown in 20%s since non-operating income is increased.

According to the analysis by yakup(www.yakup.com), the 2014 first half sales performance of the KOSPI and KOSDAQ pharmaceuticals is shown an average 5.9% increase.

In contrast, operat...